- Pro Medicus (PME) subsidiary Visage Imaging signs an eight-year, $12 million contract with US-based Samaritan Health Services
- Under the contract, Samaritan will replace its existing PACS network with Pro Medicus’ Visage 7 technology
- Pro Medicus CEO Sam Hupert says the deal further solidifies the company’s presence in the Northwest region of the US
- The rollout will start now, with “go-lives” expected in the second half of 2023
- Pro Medicus shares are up 1.63 per cent and trading at $66.13 at 10:56 am AEDT
Pro Medicus’ (PME) wholly-owned subsidiary, Visage Imaging, has signed an eight-year, $12 million contract with US-based Samaritan Health Services.
The contract will see the Samaritan tech network receive an overhaul, with the organisation to replace its existing electronic picture archiving and communications system (PACS) with Pro Medicus’ Visage 7 platform.
The cloud-engineered Visage 7 tech offering includes open archive and workflow modules to be implemented throughout Samaritan’s Oregon-based health services network, creating a “unified diagnostic imaging platform” across the organisation.
Samaritan’s network includes five hospitals in the mid-Willamette Valley and central Oregon Coast.
Pro Medicus CEO Sam Hupert said the contract added to the company’s growing portfolio in the region.
“Samaritan joins our growing list of IDN (integrated delivery network) clients and will reinforce our strong presence in the Northwest region of the United States,” Dr Hupert said.
“IDNs are the largest market segment in North America, and this is our fifth material IDN contract in the last 12 months.”
Visage 7 will be installed in the cloud — a trend that has become a common theme within the US healthcare IT market.
“This deal represents another ‘full-stack’ Visage 7 solution comprising all three Visage products — namely viewer, workflow and archive — and builds on our increasing momentum in the IDN space,” Dr Hupert added.
“It also reinforces our view that our platform is equally suited to mid-sized IDNs as it is to the larger ones, enabling us to address multiple segments of this important market.”
The rollout will start now, with go-lives expected in the second half of 2023.
Pro Medicus shares were up 1.63 per cent and trading at $66.13 at 10:56 am AEDT.